Approvals/TGA/EXFORGE HCT 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide combination tablet blister pack

Approved

STANDARD

EXFORGE HCT 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide combination tablet blister pack

Approval Id: 2b9d96d312371a73
Product Name: EXFORGE HCT 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide combination tablet blister pack
Artg Id: 157954
Artg Name: EXFORGE HCT 5/160/12.5 amlodipine/valsartan/hydrochlorothiazide tablet blister pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2010-04-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/fe99f79db3ca7ca1162161e6a2fe517a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/4a79584dd77fb171da9572137027bd6b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

2b9d96d312371a73

Type

Standard